¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Çâ, ¾÷°è ºÐ¼®(¸¶½ºÅ© º°¡¤¿ëµµº°, Áö¿ªº°), ¿¹Ãø(2025-2034³â)
Artificial Ventilation And Anesthesia Masks Market Size, Share, Trends & Industry Analysis Report: By Mask (Disposable Masks and Reusable Masks), By Application, and By Region - Market Forecast, 2025-2034
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è ÀΰøÈ£Èí±â ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 39¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
ÀΰøÈ£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå¿¡´Â ȯÀÚ¿¡°Ô È£Èí º¸Á¶ ¹× ¸¶Ãë °¡½º¸¦ °ø±ÞÇϱâ À§ÇØ ¼³°èµÈ Ư¼ö ÀÇ·á±â±â°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¸¶½ºÅ©´Â ´Ù¾çÇÑ ÀÇ·á ÀýÂ÷, ƯÈ÷ ¼ö¼ú Áß È¯ÀÚÀÇ ±âµµ¸¦ À¯ÁöÇϰí ÀûÀýÇÑ °¡½º ±³È¯À» º¸ÀåÇϸç È£Èí ±â´ÉÀÌ ÀúÇÏµÈ È¯ÀÚ¸¦ Áö¿øÇϱâ À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÇ·á Àü¹®°¡¿¡°Ô´Â ´Ù¾çÇÑ ÀÓ»ó ÇöÀå¿¡¼ ȯÀÚÀÇ È£ÈíÀ» ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù.
ÀΰøÈ£Èí±â ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ Å©°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, COPD ¹× õ½Ä°ú °°Àº ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ´õºÒ¾î Àü ¼¼°èÀûÀ¸·Î ¿Ü°ú ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ Çʼö Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î °í·ÉȰ¡ ÁøÇàµÇ¸é¼ ¼ö¼ú°ú È£Èí±â Áúȯ¿¡ °É¸®±â ½¬¿öÁø °Íµµ ½ÃÀåÀÇ ²ÙÁØÇÑ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Æí¾ÈÇÔ°ú ¹ÐÆó¼ºÀ» Çâ»ó½ÃŰ´Â ¸¶½ºÅ© µðÀÚÀÎÀÇ °³¼±, ÀÏȸ¿ë ¸¶½ºÅ©ÀÇ Ã¤Åà Áõ°¡·Î À̾îÁö´Â °¨¿° °ü¸®ÀÇ Á߿伺 Áõ°¡ µî ±â¼ú ¹ßÀüµµ ½ÃÀåÀÇ ±àÁ¤ÀûÀÎ Àü¸ÁÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.
ÀΰøÈ£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀå º¸°í¼ ÇÏÀ̶óÀÌÆ®
¸¶½ºÅ© À¯Çüº°·Î´Â ÀÏȸ¿ë ¸¶½ºÅ©°¡ 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â °¨¿° °ü¸®ÀÇ Å« ÀåÁ¡°ú ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼ »ç¿ëÇϱ⠽±±â ¶§¹®ÀÔ´Ï´Ù. ÀÏȸ¿ë ¸¶½ºÅ©´Â ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÃÖ¼ÒÈÇÏ°í º´¿ø ¹× Ŭ¸®´ÐÀÇ È¯ÀÚ ¾ÈÀü ÇÁ·ÎÅäÄÝ¿¡ ºÎÇÕÇÕ´Ï´Ù.
¿ëµµº°·Î´Â ¼ö¼ú½ÇÀÌ 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â ÁÖ·Î Àü½Å ¸¶Ãë°¡ ÇÊ¿äÇÑ °ÅÀÇ ¸ðµç ¼ö¼ú¿¡¼ °¡½º °ø±Þ°ú ±âµµ °ü¸®¸¦ À§ÇØ ¸¶½ºÅ©¸¦ »ç¿ëÇØ¾ß Çϱ⠶§¹®ÀÔ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¼ö¼ú °Ç¼ö°¡ ¸¹±â ¶§¹®¿¡ ÀÌ ¿ëµµ´Â ¾ÈÁ¤ÀûÀ̰í Å« ¼ö¿ä¸¦ º¸ÀåÇÕ´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ÀΰøÈ£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå¿¡¼ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ºÏ¹Ì´Â ÀΰøÈ£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ±× ¹è°æ¿¡´Â ¼±ÁøÈµÈ ÀÇ·á ÀÎÇÁ¶ó¿Í ³ôÀº ÀÇ·áºñ ÁöÃâÀÌ ÀÖ½À´Ï´Ù.
½ÃÀå ÁÖ¿ä ±â¾÷À¸·Î´Â KGaA,Koninklijke Philips N.V.,Medtronic,Fisher &Paykel Healthcare Limited,Getinge AB,ResMed,Teleflex, Inc. Incorporated,GE Healthcare,B. Braun Melsungen AG,Smiths Group plc,GaleMed Corporation,Vyaire Medical, Inc. µîÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ºÐ¼® ¹æ¹ý
Á¦4Àå ¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå ÀλçÀÌÆ®
- ½ÃÀå ÇöȲ
- Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
- PESTLE ºÐ¼®
- Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå µ¿Çâ
- ¹ë·ùüÀÎ ºÐ¼®
- COVID-19ÀÇ ¿µÇ⠺м®
Á¦5Àå ¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå : ¸¶½ºÅ©º°
- ÁÖ¿ä ºÐ¼® °á°ú
- ¼·Ð
- ÀÏȸ¿ë ¸¶½ºÅ©
- ÀçÀÌ¿ë ¸¶½ºÅ©
Á¦6Àå ¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå : ¿ëµµº°
- ÁÖ¿ä ºÐ¼® °á°ú
- ¼·Ð
- ¼ö¼ú½Ç
- ÁýÁß Ä¡·á½Ç
- ±¸±Þ½Ç
- ÀÚÅÃ ÀÇ·á
- ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
Á¦7Àå ¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå : Áö¿ªº°
- ÁÖ¿ä ºÐ¼® °á°ú
- ¼·Ð
- Àΰø È£Èí ¹× ¸¶Ãë¿ë ¸¶½ºÅ© ½ÃÀå ºÐ¼® : Áö¿ªº°(2020-2034³â)
- ºÏ¹Ì
- ºÏ¹Ì : ¸¶½ºÅ©º°(2020-2034³â)
- ºÏ¹Ì : ¿ëµµº°(2020-2034³â)
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- À¯·´ : ¸¶½ºÅ©º°(2020-2034³â)
- À¯·´ : ¿ëµµº°(2020-2034³â)
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ³×´ú¶õµå
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ¸¶½ºÅ©º°(2020-2034³â)
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°(2020-2034³â)
- Áß±¹
- Àεµ
- ¸»·¹À̽þÆ
- ÀϺ»
- Àεµ³×½Ã¾Æ
- Çѱ¹
- È£ÁÖ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¸¶½ºÅ©º°(2020-2034³â)
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°(2020-2034³â)
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä« : ¸¶½ºÅ©º°(2020-2034³â)
- ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°(2020-2034³â)
- ¸ß½ÃÄÚ
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦8Àå °æÀï ±¸µµ
- »ç¾÷ È®´ë ¹× ±â¾÷ Àμö ºÐ¼®
- Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦9Àå ±â¾÷ °³¿ä
- B. Braun Melsungen AG
- Dragerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare Limited
- GaleMed Corporation
- GE HealthCare
- Getinge AB
- Koninklijke Philips N.V.
- Medtronic
- ResMed
- Smiths Group plc
- Teleflex Incorporated
- Vyaire Medical, Inc.
LSH
The global artificial ventilation and anesthesia masks market size is expected to reach USD 3.90 billion by 2034, according to a new study by Polaris Market Research. The report "Artificial Ventilation And Anesthesia Masks Market Size, Share, Trends & Industry Analysis Report: By Mask (Disposable Masks and Reusable Masks), By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The artificial ventilation and anesthesia masks market encompasses specialized medical devices designed to deliver respiratory support and anesthetic gases to patients. These masks are crucial for maintaining a patient's airway and ensuring proper gas exchange during various medical procedures, particularly surgeries, and for supporting individuals with compromised breathing functions. They are essential tools for healthcare professionals in managing patient respiration safely and effectively across a range of clinical settings.
The artificial ventilation and anesthesia masks market is experiencing significant growth driven by several key factors. The global increase in surgical procedures, alongside the rising prevalence of chronic respiratory diseases such as COPD and asthma, continually boosts demand for these essential devices. Furthermore, the world's aging population, which is more susceptible to both surgical interventions and respiratory ailments, contributes to a steady expansion of the market. Technological advancements, including improved mask designs for comfort and better sealing, and the growing emphasis on infection control leading to increased adoption of disposable masks, are also shaping the market's positive outlook.
Artificial Ventilation And Anesthesia Masks Market Report Highlights:
By mask, disposable masks held the largest share in 2024 due to their significant advantages in infection control and ease of use in diverse healthcare settings. Their single-use nature helps minimize the risk of cross-contamination, aligning with patient safety protocols across hospitals and clinics.
By application, operating rooms held the largest share in 2024, primarily because nearly all surgical procedures requiring general anesthesia necessitate the use of these masks for gas delivery and airway management. The high volume of surgeries performed globally ensures a consistent and substantial demand for these devices within this application.
By region, North America held the largest share in 2024 in the artificial ventilation and anesthesia masks market. North America holds a significant share in the artificial ventilation and anesthesia masks market, driven by its advanced healthcare infrastructure and high healthcare spending.
Key players in the market include Dragerwerk AG & Co. KGaA, Koninklijke Philips N.V., Medtronic, Fisher & Paykel Healthcare Limited, Getinge AB, ResMed, Teleflex Incorporated, GE HealthCare, B. Braun Melsungen AG, Smiths Group plc, GaleMed Corporation, and Vyaire Medical, Inc.
Polaris Market Research has segmented the Artificial Ventilation and Anesthesia Masks market report based on mask, application, and region:
By Mask Outlook (Revenue - USD Billion, 2020-2034)
Disposable Masks
Reusable Masks
By Application Outlook (Revenue - USD Billion, 2020-2034)
Operating Rooms
ICU
Emergency Rooms
Homecare
ASCs
By Regional Outlook (Revenue - USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Artificial Ventilation And Anesthesia Masks Market Insights
- 4.1. Artificial Ventilation And Anesthesia Masks Market - Market Snapshot
- 4.2. Artificial Ventilation And Anesthesia Masks Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Number of Surgical Procedures
- 4.2.1.2. Rising Prevalence of Chronic Respiratory Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of advanced masks
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Artificial Ventilation And Anesthesia Masks Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Artificial Ventilation And Anesthesia Masks Market, by Mask
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 5.3. Disposable Masks
- 5.3.1. Global Artificial Ventilation And Anesthesia Masks Market, by Disposable Masks, by Region, 2020-2034 (USD Billion)
- 5.4. Reusable Masks
- 5.4.1. Global Artificial Ventilation And Anesthesia Masks Market, by Reusable Masks, by Region, 2020-2034 (USD Billion)
6. Global Artificial Ventilation And Anesthesia Masks Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 6.3. Operating Rooms
- 6.3.1. Global Artificial Ventilation And Anesthesia Masks Market, by Operating Rooms, by Region, 2020-2034 (USD Billion)
- 6.4. ICU
- 6.4.1. Global Artificial Ventilation And Anesthesia Masks Market, by ICU, by Region, 2020-2034 (USD Billion)
- 6.5. Emergency Rooms
- 6.5.1. Global Artificial Ventilation And Anesthesia Masks Market, by Emergency Rooms, by Region, 2020-2034 (USD Billion)
- 6.6. Homecare
- 6.6.1. Global Artificial Ventilation And Anesthesia Masks Market, by Homecare, by Region, 2020-2034 (USD Billion)
- 6.7. ASCs
- 6.7.1. Global Artificial Ventilation And Anesthesia Masks Market, by ASCs, by Region, 2020-2034 (USD Billion)
7. Global Artificial Ventilation And Anesthesia Masks Market, by Geography
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Artificial Ventilation And Anesthesia Masks Market Assessment, By Geography, 2020-2034 (USD Billion)
- 7.3. Artificial Ventilation And Anesthesia Masks Market - North America
- 7.3.1. North America: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.3.2. North America: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.3.3. Artificial Ventilation And Anesthesia Masks Market - U.S.
- 7.3.3.1. U.S.: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.3.3.2. U.S.: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.3.4. Artificial Ventilation And Anesthesia Masks Market - Canada
- 7.3.4.1. Canada: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.3.4.2. Canada: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4. Artificial Ventilation And Anesthesia Masks Market - Europe
- 7.4.1. Europe: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.2. Europe: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.3. Artificial Ventilation And Anesthesia Masks Market - UK
- 7.4.3.1. UK: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.3.2. UK: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.4. Artificial Ventilation And Anesthesia Masks Market - France
- 7.4.4.1. France: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.4.2. France: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.5. Artificial Ventilation And Anesthesia Masks Market - Germany
- 7.4.5.1. Germany: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.5.2. Germany: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.6. Artificial Ventilation And Anesthesia Masks Market - Italy
- 7.4.6.1. Italy: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.6.2. Italy: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.7. Artificial Ventilation And Anesthesia Masks Market - Spain
- 7.4.7.1. Spain: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.7.2. Spain: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.8. Artificial Ventilation And Anesthesia Masks Market - Netherlands
- 7.4.8.1. Netherlands: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.8.2. Netherlands: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.9. Artificial Ventilation And Anesthesia Masks Market - Russia
- 7.4.9.1. Russia: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.9.2. Russia: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.4.10. Artificial Ventilation And Anesthesia Masks Market - Rest of Europe
- 7.4.10.1. Rest of Europe: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.4.10.2. Rest of Europe: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5. Artificial Ventilation And Anesthesia Masks Market - Asia Pacific
- 7.5.1. Asia Pacific: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.3. Artificial Ventilation And Anesthesia Masks Market - China
- 7.5.3.1. China: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.3.2. China: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.4. Artificial Ventilation And Anesthesia Masks Market - India
- 7.5.4.1. India: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.4.2. India: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.5. Artificial Ventilation And Anesthesia Masks Market - Malaysia
- 7.5.5.1. Malaysia: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.5.2. Malaysia: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.6. Artificial Ventilation And Anesthesia Masks Market - Japan
- 7.5.6.1. Japan: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.6.2. Japan: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.7. Artificial Ventilation And Anesthesia Masks Market - Indonesia
- 7.5.7.1. Indonesia: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.7.2. Indonesia: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.8. Artificial Ventilation And Anesthesia Masks Market - South Korea
- 7.5.8.1. South Korea: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.8.2. South Korea: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.9. Artificial Ventilation And Anesthesia Masks Market - Australia
- 7.5.9.1. Australia: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.9.2. Australia: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.5.10. Artificial Ventilation And Anesthesia Masks Market - Rest of Asia Pacific
- 7.5.10.1. Rest of Asia Pacific: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.5.10.2. Rest of Asia Pacific: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.6. Artificial Ventilation And Anesthesia Masks Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.6.3. Artificial Ventilation And Anesthesia Masks Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.6.3.2. Saudi Arabia: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.6.4. Artificial Ventilation And Anesthesia Masks Market - UAE
- 7.6.4.1. UAE: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.6.4.2. UAE: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.6.5. Artificial Ventilation And Anesthesia Masks Market - Israel
- 7.6.5.1. Israel: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.6.5.2. Israel: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.6.6. Artificial Ventilation And Anesthesia Masks Market - South Africa
- 7.6.6.1. South Africa: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.6.6.2. South Africa: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.6.7. Artificial Ventilation And Anesthesia Masks Market - Rest of Middle East & Africa
- 7.6.7.1. Rest of Middle East & Africa: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.6.7.2. Rest of Middle East & Africa: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.7. Artificial Ventilation And Anesthesia Masks Market - Latin America
- 7.7.1. Latin America: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.7.3. Artificial Ventilation And Anesthesia Masks Market - Mexico
- 7.7.3.1. Mexico: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.7.3.2. Mexico: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.7.4. Artificial Ventilation And Anesthesia Masks Market - Brazil
- 7.7.4.1. Brazil: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.7.4.2. Brazil: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.7.5. Artificial Ventilation And Anesthesia Masks Market - Argentina
- 7.7.5.1. Argentina: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.7.5.2. Argentina: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
- 7.7.6. Artificial Ventilation And Anesthesia Masks Market - Rest of Latin America
- 7.7.6.1. Rest of Latin America: Artificial Ventilation And Anesthesia Masks Market, by Mask, 2020-2034 (USD Billion)
- 7.7.6.2. Rest of Latin America: Artificial Ventilation And Anesthesia Masks Market, by Application, 2020-2034 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. B. Braun Melsungen AG
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Dragerwerk AG & Co. KGaA
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Fisher & Paykel Healthcare Limited
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. GaleMed Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. GE HealthCare
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Getinge AB
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Koninklijke Philips N.V.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Medtronic
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. ResMed
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Smiths Group plc
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Teleflex Incorporated
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Vyaire Medical, Inc.
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development